Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AQSTthis companyAquestive Therapeutics, Inc.	$3.66	-8.5×	-23.41×	17.69×	-12.07×	-157.6%	61.5%	-156.4%	-188.1%	248.9%	-56.0%	-6.7%	-3.9×	-0.16×	-4.07×	3.14×	0.0%	3	-3.77	2	C
AMPHAmphastar Pharmaceuticals, Inc.	$28.74	12.75×	1.59×	1.74×	8.18×	241.3%	49.5%	19.5%	13.6%	12.4%	7.5%	9.7%	0.83×	2.29×	5.51×	4.02×	0.0%	6	2.19	4	A-
AYTUAytu BioPharma, Inc.	$1.86	-1.85×	0.75×	0.46×	-4.17×	-322.8%	64.0%	-14.4%	-24.8%	-40.4%	-14.2%	12.3%	0.51×	1.87×	4.39×	1.13×	0.0%	4	-4.22	2	C
COLLCollegium Pharmaceutical, Inc.	$24.61	23.38×	4.87×	1.88×	5.38×	2688.6%	59.3%	24.0%	8.1%	20.8%	10.2%	22.3%	3.12×	1.72×	2.27×	1.57×	0.0%	5	0.95	3	B-
CPIXCumberland Pharmaceuticals Inc.	$5.45	-20.95×	2.39×	1.34×	19.7×	-102.6%	85.0%	-6.3%	-6.4%	-11.4%	-6.9%	8.1%	0.41×	-0.43×	-5.63×	1.01×	0.0%	3	0.04	2	C
DERMJourney Medical Corporation	$4.55	-16.4×	5.93×	3.05×	-57.16×	-300.3%	59.3%	-13.2%	-18.5%	-35.9%	-14.3%	-6.6%	0.8×	-0.39×	-2.21×	1.79×	0.0%	4	0.73	1	D+
Peer median	—	-1.85×	2.39×	1.74×	5.38×	-102.6%	59.3%	-6.3%	-6.4%	-11.4%	-6.9%	9.7%	0.8×	1.72×	2.27×	1.57×	0.0%	4	0.73	2	—